Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Seeks Higher Quality Responses To Form 483 Inspection Findings
Mar 23 2026
•
By
Sue Sutter
The FDA explains how manufacturers should respond to inspection observations.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from United States